Clinical Trial Update: A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Duloxetine (LY248686) in diabetic peripheral neuropathic pain has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathic Pain

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 4 | Status: COMPLETED | Results posted: 2018-07-10